Novel mutations in the respiratory syncytial virus G gene identified in viral isolates from a girl with severe combined immune deficiency treated with intravenous immune globulin

J Clin Virol. 2006 Nov;37(3):168-73. doi: 10.1016/j.jcv.2006.07.006. Epub 2006 Sep 1.

Abstract

Background: Respiratory syncytial virus (RSV) can cause prolonged infections in individuals with compromised immunity.

Objectives: To investigate whether RSV evolves during prolonged infection in an immunocompromised host.

Study design: We sequenced the envalope glycoprotein genes of RSV obtained at three time points during a 59-day period from a 4-year-old female with severe combined immune deficiency (SCID) treated with intravenous immunoglobulin (IVIG).

Results: Sporadic silent mutations were found in the SH, G and F genes among three RSV samples collected at days 0, 19 and 59. Premature stop codons at amino acid positions 257 and 278 were present in the RSV G glycoprotein gene sequenced from each time point. None of the 48 RSV G sequences available on GenBank or any of 50 genetically diverse clinical isolates of RSV contained these mutations. These premature stop codon mutations occurred at the same positions of the G glycoprotein gene as those described in in vitro monoclonal-antibody resistant mutants reported elsewhere.

Conclusion: Our patient was most likely infected with a single RSV strain that did not mutate during the study period. This strain contains unique mutations that may have previously evolved in this individual who had prolonged infection and was treated with monthly IVIG.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Child, Preschool
  • Female
  • Genes, Viral*
  • Humans
  • Immunocompromised Host
  • Immunoglobulins, Intravenous / therapeutic use*
  • Molecular Sequence Data
  • Mutation
  • Phylogeny
  • Respiratory Syncytial Virus Infections / genetics*
  • Respiratory Syncytial Virus Infections / immunology
  • Respiratory Syncytial Virus Infections / therapy
  • Respiratory Syncytial Virus, Human / genetics*
  • Sequence Homology, Amino Acid
  • Severe Combined Immunodeficiency / complications
  • Severe Combined Immunodeficiency / therapy*
  • Viral Envelope Proteins / genetics
  • Virus Shedding / genetics

Substances

  • Immunoglobulins, Intravenous
  • Viral Envelope Proteins